iX Biopharma42C 
$0.023.85%24h
3.85%24h
Global rank31059
Market cap$15.96M
Change 7d3.85%
YTD Performance-40.00%
SP500 benchmarkUnderperform
P/E0
P/S3.50
Revenue$4.56M
Earnings-$7.42M
Dividend yield-
Main Sector
Healthcare
Category
iX Biopharma (42C) Net Assets
42C Net Assets in 2023: $15.85M
As of 21 Nov 2024, iX Biopharma net assets is $15.85M, an decrease of -19.71% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the iX Biopharma overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
iX Biopharma Net Assets History from 2019 to 2024
-
Value:-
42C Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $15.85M | -19.71% |
| 2022 | $19.74M | 68.59% |
| 2021 | $11.71M | 15.18% |
| 2020 | $10.17M | -44.40% |
| 2019 | $18.29M | - |
View the Top Net Assets Companies
